LIXTE BIOTECHNOLOGY HOLDINGS, INC. Cash Flow Statement
LIXT|4 years of annual SEC 10-K data (FY2011-FY2015)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 4 fiscal years. All figures from audited SEC 10-K filings.
LIXTE BIOTECHNOLOGY HOLDINGS, INC. used $2M in operating cash flow in FY2015.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -11.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2015 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|
| Net Income | -$2.8M | -$16.1K | -$16.1K | -$16.1K |
| Depreciation & Amortization | - | $0 | $0 | $0 |
| Operating Cash Flow | -$1.6M | -$1.2M | -$1.4M | -$936.4K |